Immunology of COVID-19: Current State of the Science

  title={Immunology of COVID-19: Current State of the Science},
  author={N. Vabret and G. Britton and C. Gruber and S. Hegde and J. Kim and Maria Kuksin and Rachel Levantovsky and L. Malle and Alvaro Moreira and Matthew D. Park and Luisanna Pia and Emma Risson and Miriam Saffern and B. Salom{\'e} and M. E. Selvan and M. P. Spindler and Jessica Tan and Verena van der Heide and Jill K. Gregory and K. Alexandropoulos and N. Bhardwaj and B. Brown and B. Greenbaum and Zeynep H. G{\"u}m{\"u}ş and D. Homann and Amir Horowitz and A. Kamphorst and M. A. Curotto de Lafaille and S. Mehandru and M. Merad and R. Samstein},
  pages={910 - 941}
  • N. Vabret, G. Britton, +28 authors R. Samstein
  • Published 2020
  • Biology, Medicine
  • Immunity
  • Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting an unprecedented effort from the scientific community to understand the biological underpinning of COVID19 pathophysiology. In this review, we summarize the current state of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute… CONTINUE READING
    280 Citations

    Tables and Topics from this paper.

    Immunopathology of Hyperinflammation in COVID-19
    • 1
    T cell immunity to SARS-CoV-2 following natural infection and vaccination
    Fundamental Basis of COVID-19 Pathogenesis


    COVID-19: immunopathology and its implications for therapy
    • X. Cao
    • Medicine
    • Nature Reviews Immunology
    • 2020
    • 344
    • PDF
    Is COVID-19 receiving ADE from other coronaviruses?
    • J. Tetro
    • Medicine, Biology
    • Microbes and Infection
    • 2020
    • 182
    Immunopathogenesis of coronavirus infections: implications for SARS
    • 268
    • PDF
    SARS and MERS: recent insights into emerging coronaviruses
    • 1,199
    • PDF
    COVID-19: a new virus, but an old cytokine release syndrome
    • 5
    • Highly Influential
    SARS-CoV-2 Vaccines: Status Report
    • 331
    • PDF
    The spike protein of SARS-CoV — a target for vaccine and therapeutic development
    • 589
    • Highly Influential
    • PDF
    Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors
    • 104
    • Highly Influential
    • PDF